This means medicine or fluids are given under your skin, not directly into a vein. It's a common method for delivering fluids or medications.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
A subcutaneous infusion delivers fluid or medicine slowly into the layer of fat just under the skin rather than into a vein. A fine needle or soft plastic tube sits under the skin, and the fluid is absorbed from there into the bloodstream over hours. Because no vein is needed, it is simpler to start than an intravenous (IV) line, and it can be given in a hospital, a nursing home or at home. It is used in three main situations. The first is hydration, sometimes called hypodermoclysis: giving salt-water fluid to someone, most often an older adult, who is mildly to moderately dehydrated or not drinking enough during an illness. In older adults it rehydrates about as well as IV fluids, and in people who are confused it causes less agitation and fewer pulled-out lines. The second is palliative and end-of-life care, where a small battery-powered pump, often called a syringe driver, gives pain, nausea and other symptom medicines around the clock when swallowing is no longer possible or reliable. The third is long-term treatment that many people give themselves at home, most notably immune globulin (antibody) replacement for people whose immune systems do not make enough antibodies, using products such as Hizentra. A few other medicines, such as deferoxamine for iron overload, are also given this way. The route has real limits. Fluid absorbs slowly, so subcutaneous hydration usually tops out at about 1 to 1.5 liters a day. It is not suitable for severe dehydration, shock, serious salt imbalances or anyone who needs fluid quickly; those situations call for an IV. It also works poorly when the body is already swollen with fluid or the blood protein albumin is very low. In advanced illness, when someone can no longer swallow and is not expected to regain that ability, the benefit of added fluids is uncertain, and many families and care teams choose a comfort-focused approach without them.
Preparation is usually light, and it depends on why the infusion is being given. For hydration, the team judges how dehydrated the person is, often with blood tests of kidney function and salts, and chooses the fluid and amount. Tell the team about medicine allergies and about any swelling in the legs or body, since fluid absorbs poorly into tissue that is already swollen. For a palliative syringe driver, the care team explains which medicines are in the pump, that it is usually refilled once every 24 hours, and who to contact if symptoms break through. At home this relies on visiting nurses and on medicines and equipment being arranged ahead of time, so it helps to confirm those arrangements before discharge. For immune globulin at home, a nurse or specialty pharmacy trains the person or a caregiver to set up the pump, prepare the medicine, choose and clean the sites, and keep a log of each infusion. People infuse on their own only after showing they can do it independently. Blood tests of antibody (IgG) levels guide the dose over time.
The skin is cleaned and a short, fine needle or soft plastic cannula is slid in at an angle into the fatty layer, which usually feels like a quick pinch. Common sites are the abdomen, thighs and upper arms, and for someone who may pull at a line, the upper back between the shoulder blades, where it is out of reach. Bony areas, joints, scars, damaged or irradiated skin and swollen limbs are avoided. A clear dressing holds the line in place. Fluid then runs in from a bag by gravity or through a pump. Hydration often runs over several hours or overnight (about a liter over 8 hours is a common pace), and the person can usually rest, move about or eat during it. A syringe driver runs continuously. Immune globulin is pumped into one or several sites at once, on a schedule that ranges from daily to every two weeks. A soft, puffy swelling at the site while the fluid absorbs is expected.
There is little recovery in the usual sense. When an infusion ends, the needle is removed and a small bandage applied. Mild swelling, redness, tenderness or a small bruise at the site is common and usually settles without treatment. Sites are rotated, and how long a line stays in place varies from a couple of days to about a week depending on the setting and device. For hydration, the team watches whether the person is drinking more, passing urine and improving, and stops once drinking is enough. In palliative care, nurses check the site and pump regularly and adjust medicines as needs change; the pump can be changed early if symptoms such as pain are not controlled, so there is no need to wait for the next daily refill. People using immune globulin keep their infusion log and have periodic antibody-level checks. Contact the care team if a site reaction gets worse or lasts more than a few days, or if the line leaks or comes out.
Subcutaneous infusions are generally low risk. Local reactions (swelling, redness, discomfort or itching at the site) are the most common problem and usually resolve on their own. Unlike an IV, the route cannot cause vein inflammation (phlebitis) or a line-related bloodstream infection, and the line is less often dislodged. The main limits are about fit rather than danger. Because fluid absorbs slowly, this route falls short when someone needs a lot of fluid or needs it fast, and an unsuitable fluid can disturb the body's salt balance. That is why the team reserves it for mild to moderate dehydration and chooses the fluid. Continuous infusions in palliative care depend on a chain of steps: prescribing, supply of medicines and equipment, setting up the pump and monitoring it. Breakdowns in that chain, especially when care passes between hospital and home, are a recognized source of medication errors, so it is worth knowing who is responsible for the pump and how to reach them at any hour. With immune globulin, the important risks come from the medicine rather than the route. Its label carries a boxed warning for blood clots, which are more likely with older age, immobility, estrogen use, a past clot or heart and blood vessel risk factors. Report pain or swelling with warmth in an arm or leg, or unexplained shortness of breath, to the care team right away. Stop the infusion and get emergency care for chest pain, sudden numbness or weakness on one side of the body, or signs of a severe allergic reaction such as hives with wheezing or chest tightness. People with IgA deficiency who have antibodies against IgA are at higher risk of severe allergic reactions.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Subcutaneous Infusion, what to expect, or ask the community a question.